IQVIA Holdings Other Non-Current Liabilities 2011-2025 | IQV
IQVIA Holdings other non-current liabilities from 2011 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- IQVIA Holdings other non-current liabilities for the quarter ending March 31, 2025 were $676M, a 13.61% increase year-over-year.
- IQVIA Holdings other non-current liabilities for 2024 were $0.668B, a 4.3% decline from 2023.
- IQVIA Holdings other non-current liabilities for 2023 were $0.698B, a 4.02% increase from 2022.
- IQVIA Holdings other non-current liabilities for 2022 were $0.671B, a 3.39% increase from 2021.
| IQVIA Holdings Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $668 |
| 2023 | $698 |
| 2022 | $671 |
| 2021 | $649 |
| 2020 | $633 |
| 2019 | $456 |
| 2018 | $418 |
| 2017 | $440 |
| 2016 | $402 |
| 2015 | $183 |
| 2014 | $184 |
| 2013 | $179 |
| 2012 | $171 |
| 2011 | $139 |
| 2010 | $0 |
| IQVIA Holdings Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $676 |
| 2024-12-31 | $668 |
| 2024-09-30 | $612 |
| 2024-06-30 | $632 |
| 2024-03-31 | $595 |
| 2023-12-31 | $698 |
| 2023-09-30 | $679 |
| 2023-06-30 | $703 |
| 2023-03-31 | $641 |
| 2022-12-31 | $671 |
| 2022-09-30 | $561 |
| 2022-06-30 | $563 |
| 2022-03-31 | $581 |
| 2021-12-31 | $649 |
| 2021-09-30 | $656 |
| 2021-06-30 | $607 |
| 2021-03-31 | $586 |
| 2020-12-31 | $633 |
| 2020-09-30 | $580 |
| 2020-06-30 | $582 |
| 2020-03-31 | $491 |
| 2019-12-31 | $456 |
| 2019-09-30 | $431 |
| 2019-06-30 | $424 |
| 2019-03-31 | $412 |
| 2018-12-31 | $418 |
| 2018-09-30 | $406 |
| 2018-06-30 | $406 |
| 2018-03-31 | $413 |
| 2017-12-31 | $440 |
| 2017-09-30 | $420 |
| 2017-06-30 | $421 |
| 2017-03-31 | $393 |
| 2016-12-31 | $402 |
| 2016-09-30 | $191 |
| 2016-06-30 | $181 |
| 2016-03-31 | $187 |
| 2015-12-31 | $183 |
| 2015-09-30 | $170 |
| 2015-06-30 | $191 |
| 2015-03-31 | $181 |
| 2014-12-31 | $184 |
| 2014-09-30 | $168 |
| 2014-06-30 | $186 |
| 2014-03-31 | $178 |
| 2013-12-31 | $179 |
| 2013-09-30 | $161 |
| 2013-06-30 | $154 |
| 2013-03-31 | $156 |
| 2012-12-31 | $171 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $139 |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.775B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Alcon (ALC) | Switzerland | $47.228B | 31.39 |
| Edwards Lifesciences (EW) | United States | $43.221B | 28.34 |
| IDEXX Laboratories (IDXX) | United States | $39.544B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.32 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.518B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.22 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |